1

Prevalence and Clinical Correlates of Myositis Specific Autoantibodies in Idiopathic Immune-Mediated Inflammatory Myositis - Results from a Multicentric Cohort (MyoIN) from India

Liza Rajasekhar, Vineeta Shobha, Anitha Narasimhan, Vasudha Bhat, SN Amin, Ramnath Misra

2

Low-dose rituximab is efficacious in refractory idiopathic inflammatory myopathies

Ramya Janardana, S.N. Amin, Liza Rajasekhar, Benzeeta Pinto, Chanakya Kodishala, Sumithra Selvam,Vineeta Shobha

3

Fever, Cutaneous Ulcers, and Arthritis Define the MDA5 Phenotype in Indian Patients with Idiopathic Inflammatory Myositis

Phanikumar Devarasetti , Irfan Mohammad , Anitha Desai, Liza Rajasekhar

Clinical profile and treatment outcomes in antisynthetase syndrome: a tertiary centre experience

5

Comparison of Muscle Biopsy Features with Myositis Autoantibodies in Inflammatory Myopathies: A Pilot Experience

Archana Gudipati, Shaikh Rifat, Megha Uppin, Afshan Jabeen, Niharika L. Mathukumalli, Sireesha Yareeda, Sunitha Kayidhi, Anjan Pyal, Megha Dhamne, Y Muralidhar Reddy

6

Long Term Outcomes in Idiopathic Inflammatory Myositis: An Observational Epidemiologic Study over 15 Years

Ramya Janardana,Sangeetha KN, Vasudha Bhat, Divya Balakrishnan, John Michael Raj,Benzeeta Pinto, Chanakya K, Raghunandan Nadig, Anita Mahadevan, Vineeta Shobha

7

International Guideline for Idiopathic Inflammatory Myopathy-Associated Cancer Screening: an International Myositis Assessment and Clinical Studies Group (IMACS) initiative

A list of authors and their affiliations appears at the end of the paper